Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus O Butler

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Clinical, Cosmetic and Investigational Dermatology|December 26, 2025
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin PhototypesCynthia Fournier, Maxwell B Sauder, Joel Claveau, et al.
Blood|June 17, 2006
Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemiaNaoto Hirano, Marcus O Butler, Zhinan Xia, et al.
The Journal of Reproductive Medicine|August 30, 2008
Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancyZoltan Nagymanyoki, Marcus O Butler, Michael J Callahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2017
A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1<sup>+</sup> TCRsTingxi Guo, Ming Yin Koo, Yuki Kagoya, et al.
JCI Insight|February 1, 2017
Transient stimulation expands superior antitumor T cells for adoptive therapyYuki Kagoya, Munehide Nakatsugawa, Toshiki Ochi, et al.
Oncology Letters|February 20, 2016
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanomaLeila Khoja, Eshetu G Atenafu, Qian Ye, et al.
British Journal of Cancer|October 5, 2016
Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patientsLeila Khoja, Minnie Kibiro, Ur Metser, et al.
Cancer Immunology Research|May 7, 2015
Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene TherapyToshiki Ochi, Munehide Nakatsugawa, Kenji Chamoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2012
IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cellsOsamu Imataki, Sascha Ansén, Makito Tanaka, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Clinical, Cosmetic and Investigational Dermatology|December 26, 2025
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin PhototypesCynthia Fournier, Maxwell B Sauder, Joel Claveau, et al.
Blood|June 17, 2006
Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemiaNaoto Hirano, Marcus O Butler, Zhinan Xia, et al.
The Journal of Reproductive Medicine|August 30, 2008
Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancyZoltan Nagymanyoki, Marcus O Butler, Michael J Callahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2017
A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1<sup>+</sup> TCRsTingxi Guo, Ming Yin Koo, Yuki Kagoya, et al.
JCI Insight|February 1, 2017
Transient stimulation expands superior antitumor T cells for adoptive therapyYuki Kagoya, Munehide Nakatsugawa, Toshiki Ochi, et al.
Oncology Letters|February 20, 2016
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanomaLeila Khoja, Eshetu G Atenafu, Qian Ye, et al.
British Journal of Cancer|October 5, 2016
Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patientsLeila Khoja, Minnie Kibiro, Ur Metser, et al.
Cancer Immunology Research|May 7, 2015
Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene TherapyToshiki Ochi, Munehide Nakatsugawa, Kenji Chamoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2012
IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cellsOsamu Imataki, Sascha Ansén, Makito Tanaka, et al.
Pageof 13